Search - tctmd.com

Displaying 281 - 300 of 313

Sort: Relevancy | Date

Presentation ISET 2019

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

Presenter: Gervasio A. Lamas

January 30, 2019

Presentation ISET 2019

The Role of IVC filters in PE Patients: Are filters Over-Utilized?

Presenter: Akhilesh Sista

January 30, 2019

Presentation ISET 2019

Comparing Hospital Utilization Outcomes (Catheter-Based vs Systemic Therapy) for Submassive & Massive Pulmonary Embolism

Presenter: Jack Hannallah

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

Evaluating the CLI Patient: What Testing Options Are there?

Presenter: Nicos Labropoulos

January 30, 2019

Presentation ISET 2019

Is CAS largely equivalent to CEA for the majority of patients with significant carotid disease and an indication for revascularization?

Presenter: William A. Gray

January 30, 2019

Presentation ISET 2019

Pitfalls in Carotid Diagnosis: What To Look For and How To Avoid Them

Presenter: John S. Pellerito

January 30, 2019

Presentation ISET 2019

Carotid Artery Disease: Where Does Stenting Fit in 2019?

Presenter: Chris Metzger

January 30, 2019

Presentation ISET 2019

Systemic Cardiovascular Risks in PAD Patients: The Scope of the Problem

Presenter: John Bartholomew

January 30, 2019

Presentation ISET 2019

Abdominal Aortic Aneurysms: Patient Evaluation and Management Strategy

Presenter: Geogy Vatakencherry

January 30, 2019

Presentation ISET 2019

Endovascular Treatment Options for Visceral Aneurysms

Presenter: Parag J. Patel

January 30, 2019

Presentation ISET 2019

Duplex Screening for AAA: Tecnique, When to Screen, and Whom to Screen

Presenter: Joshua Beckman

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

Presentation CHIP Florida 2019

Non crossable mid RCA

Presenter: Hady Lichaa

January 26, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

Advertisement

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

The Role of IVC filters in PE Patients: Are filters Over-Utilized?

Comparing Hospital Utilization Outcomes (Catheter-Based vs Systemic Therapy) for Submassive & Massive Pulmonary Embolism

Drug-Coated Therapy for ISR: Review of Options and Data

Evaluating the CLI Patient: What Testing Options Are there?

Is CAS largely equivalent to CEA for the majority of patients with significant carotid disease and an indication for revascularization?

Pitfalls in Carotid Diagnosis: What To Look For and How To Avoid Them

Carotid Artery Disease: Where Does Stenting Fit in 2019?

Systemic Cardiovascular Risks in PAD Patients: The Scope of the Problem

Abdominal Aortic Aneurysms: Patient Evaluation and Management Strategy

Endovascular Treatment Options for Visceral Aneurysms

Duplex Screening for AAA: Tecnique, When to Screen, and Whom to Screen

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Non crossable mid RCA

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content